Urogen Pharma Ltd. (URGN)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
03-May-22 5:19 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 30-Apr-22Option Sale 254$6.62$1,681.48(1%)
23.72K to 23.47K
03-May-22 5:19 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 30-Apr-22Option Exercise 500----2%
23.22K to 23.72K
02-Feb-22 4:35 PM
View: 
Smith Jason Drew
General Counsel
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Exercise 833----12%
7.03K to 7.86K
02-Feb-22 4:32 PM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Sale 8,195$7.58$62,118.10(3%)
316.55K to 308.36K
02-Feb-22 4:33 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Sale 1,374$7.58$10,414.90(6%)
24.59K to 23.22K
02-Feb-22 4:32 PM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Exercise 18,333----6%
298.22K to 316.55K
02-Feb-22 4:34 PM
View: 
Henderson Molly
Chief Financial Officer
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Sale 331$7.58$2,508.98(6%)
5.58K to 5.25K
02-Feb-22 4:33 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Exercise 2,500----11%
22.09K to 24.59K
02-Feb-22 4:35 PM
View: 
Smith Jason Drew
General Counsel
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Sale 414$7.58$3,138.12(5%)
7.86K to 7.45K
02-Feb-22 4:34 PM
View: 
Henderson Molly
Chief Financial Officer
Urogen Pharma Ltd. (URGN) 31-Jan-22Option Exercise 666----14%
4.91K to 5.58K
28-Jan-22 4:29 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Jan-22Option Sale 111$8.09$897.99(< 1%)
22.21K to 22.09K
28-Jan-22 4:29 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Jan-22Option Exercise 209----< 1%
22.0K to 22.21K
07-Jan-22 8:38 AM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 04-Jan-22Market Option Sale 46,968$9.15$429,757.00(14%)
345.19K to 298.22K
07-Jan-22 8:38 AM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 03-Jan-22Option Exercise 105,689----44%
239.5K to 345.19K
02-Dec-21 1:15 PM
View: 
Henderson Molly
Chief Financial Officer
Urogen Pharma Ltd. (URGN) 30-Nov-21Market Option Sale 2,587$12.03$31,121.60(34%)
7.5K to 4.91K
02-Dec-21 1:16 PM
View: 
Smith Jason Drew
General Counsel
Urogen Pharma Ltd. (URGN) 30-Nov-21Market Option Sale 3,803$12.03$45,750.10(35%)
10.83K to 7.03K
02-Dec-21 1:15 PM
View: 
Henderson Molly
Chief Financial Officer
Urogen Pharma Ltd. (URGN) 30-Nov-21Option Exercise 5,000----200%
2.5K to 7.5K
02-Dec-21 1:16 PM
View: 
Smith Jason Drew
General Counsel
Urogen Pharma Ltd. (URGN) 30-Nov-21Option Exercise 8,333----333%
2.5K to 10.83K
19-Nov-21 3:05 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 18-Nov-21Market Purchase 160$13.10$2,096.00< 1%
21.84K to 22.0K
(4%)
02-Nov-21 3:45 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 01-Nov-21Market Option Sale 258$17.16$4,427.28(1%)
22.09K to 21.84K
02-Nov-21 3:45 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 31-Oct-21Option Exercise 500----2%
21.59K to 22.09K
28-Oct-21 2:04 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 27-Oct-21Market Option Sale 107$16.32$1,746.24(< 1%)
21.7K to 21.59K
28-Oct-21 2:04 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Oct-21Option Exercise 208----< 1%
21.49K to 21.7K
03-Aug-21 7:07 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 02-Aug-21Market Option Sale 243$15.64$3,800.52(1%)
21.74K to 21.49K
03-Aug-21 7:07 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 31-Jul-21Option Exercise 500----2%
21.24K to 21.74K
28-Jul-21 9:11 AM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Jul-21Option Exercise 208----(< 1%)
21.13K to 20.92K
28-Jul-21 9:11 AM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Jul-21Market Sale 103$15.30$1,575.90(< 1%)
20.92K to 20.82K
21-May-21 1:44 PM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 19-May-21Payment of Exercise 3,425$17.51$59,968.00(1%)
242.92K to 239.5K
18-May-21 11:36 AM
View: 
Henderson Molly
Chief Financial Officer
Urogen Pharma Ltd. (URGN) 17-May-21Market Purchase 2,500$15.85$39,625.00100%
0 to 2.5K
< 1%
18-May-21 11:35 AM
View: 
Smith Jason Drew
General Counsel
Urogen Pharma Ltd. (URGN) 17-May-21Market Purchase 2,500$15.71$39,275.00100%
0 to 2.5K
2%
04-May-21 1:58 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 30-Apr-21Option Exercise 500----2%
20.88K to 21.38K
04-May-21 1:58 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 30-Apr-21Market Option Sale 243$20.00$4,860.00(1%)
21.38K to 21.13K
27-Apr-21 1:44 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Apr-21Option Exercise 209----1%
20.75K to 20.96K
27-Apr-21 1:44 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Apr-21Market Option Sale 89$19.63$1,747.07(< 1%)
20.96K to 20.88K
09-Jun-21 1:42 PM
View: 
Nussbaum Ran
Director
Urogen Pharma Ltd. (URGN) 25-Mar-21Option Exercise 2,211$5.00$11,055.00< 1%
1.43M to 1.43M
22-Apr-21 5:18 PM
View: 
Nussbaum Ran
Director
Urogen Pharma Ltd. (URGN) 24-Mar-21Option Exercise 1,030$5.00$5,150.00< 1%
1.46M to 1.47M
22-Apr-21 5:19 PM
View: 
Belldegrun Arie
Director
Urogen Pharma Ltd. (URGN) 24-Mar-21Option Exercise 3,241$5.00$16,205.001%
242.21K to 245.45K
21-May-21 1:44 PM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 31-Jan-21Option Exercise 5,000----2%
237.92K to 242.92K
02-Feb-21 2:53 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 31-Jan-21Option Exercise 2,000----10%
19.83K to 21.83K
02-Feb-21 2:53 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 31-Jan-21Market Option Sale 1,076$22.07$23,747.30(5%)
21.83K to 20.75K
26-Jan-21 5:20 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Jan-21Option Exercise 208----1%
19.72K to 19.93K
26-Jan-21 5:20 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Jan-21Market Option Sale 100$22.12$2,212.00(< 1%)
19.93K to 19.83K
21-May-21 1:44 PM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 03-Jan-21Option Exercise 8,807----4%
229.12K to 237.92K
15-Dec-20 5:27 PM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 14-Dec-20Market Purchase 10,000$18.50$185,000.005%
219.12K to 229.12K
07-Dec-20 3:59 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 04-Dec-20Option Exercise 1,042----5%
19.34K to 20.39K
07-Dec-20 3:59 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 04-Dec-20Market Option Sale 662$19.85$13,140.70(3%)
20.39K to 19.72K
04-Dec-20 4:35 PM
View: 
Barrett Elizabeth A.
Chief Executive Officer
Urogen Pharma Ltd. (URGN) 04-Dec-20Option Exercise 61,652----39%
157.47K to 219.12K
28-Oct-20 2:12 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Oct-20Option Exercise 208----1%
19.24K to 19.44K
28-Oct-20 2:12 PM
View: 
Schoenberg Mark
Chief Medical Officer
Urogen Pharma Ltd. (URGN) 26-Oct-20Market Option Sale 101$20.95$2,115.56(< 1%)
19.44K to 19.34K
16-Oct-20 3:41 PM
View: 
Pfreundschuh Peter P.
Chief Financial Officer
Urogen Pharma Ltd. (URGN) 15-Oct-20Market Option Sale 2,400$21.77$52,247.80(19%)
12.8K to 10.4K